+143.3%
MRNA vs LVS
-17.2%
+160.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | LVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.5% | -1.9% | -1.1% |
| 7D | -10.1% | -2.7% | -7.4% | -6.2% |
| 30D | +126.7% | -4.7% | +131.4% | +152.0% |
| 3M | +184.1% | -15.6% | +199.7% | +224.7% |
| 6M | +143.3% | -18.6% | +161.9% | +178.3% |
| All | +143.3% | -17.2% | +160.5% | +178.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LVS.
Daily Out/Under-Performance
Portfolio return minus LVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded LVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling